GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Net Income (Discontinued Operations)

3SBio, (FRA:YFK) Net Income (Discontinued Operations) : €0.0 Mil (TTM As of Dec. 2016)


View and export this data going back to . Start your Free Trial

What is 3SBio, Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. 3SBio,'s Net Income (Discontinued Operations) for the six months ended in Dec. 2016 was €0.0 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Dec. 2016 was €0.0 Mil.

3SBio, Net Income (Discontinued Operations) Historical Data

The historical data trend for 3SBio,'s Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio, Net Income (Discontinued Operations) Chart

3SBio, Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec14 Dec15 Dec16
Net Income (Discontinued Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

3SBio, Semi-Annual Data
Jun06 Dec06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

3SBio, Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Dec. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio, Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of 3SBio,'s Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio, (FRA:YFK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio, Inc. (FRA:YFK) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
RFL ROCO:3176 APLT CABA SRRK GRTX OSMT UBX TPE:4142 GRTS OYST SZSE:002286 CRBP TSE:7774 ROCO:6712 SZSE:002868 CDMO SZSE:002898 UROV KIN
Traded in Other Exchanges
N/A
Address
Website
http://www.3sbio.com
3SBio Inc is engaged in the healthcare sector based in China. It is a pharmaceutical products company and its core activities pertain to developing, manufacturing and marketing biopharmaceuticals. Its portfolio of products comprises of TPIAO and Yisaipu. TPIAO is the only commercialized recombinant human thrombopoietin (rhTPO) product in the world and Yisaipu is a TNF inhibibator product and accounts for the major share in the pharmaceutical industry in China. Most of the company's activities are focused on China while having a minor footprint in a foreign land.

3SBio, (FRA:YFK) Headlines

No Headlines